Trial Details

COMPLETED
Basic Information
Clinical ID c4737
Identifier NCT00048113
Trial Title Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: Alicaforsen
Participant Information
Sponsor Ionis Pharmaceuticals, Inc.
City Little Rock
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2001-01-10
Primary Completion Date 2002-04-27
Completion Date 2002-04-27